Novavax
NVAX
#5744
Rank
โ‚น114.22 B
Marketcap
โ‚น692.24
Share price
-3.24%
Change (1 day)
19.42%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): -โ‚น137.16

According to Novavax's latest financial reports the company's current EPS (TTM) is -โ‚น140.86. In 2025 the company made an earnings per share (EPS) of โ‚น253.92 an increase over its 2024 EPS that were of -โ‚น113.98.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น137.16-154.02%
2025โ‚น253.92-322.76%
2024-โ‚น113.98
2022-โ‚น769.16-64.36%
2021-โ‚น2,158243%
2020-โ‚น629.2319.75%
2019-โ‚น525.44-43.86%
2018-โ‚น935.97-19.84%
2017-โ‚น1,168-38.83%
2016-โ‚น1,90974.58%
2015-โ‚น1,09463.89%
2014-โ‚น667.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น486.52-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น65.80-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น659.81-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น266.64-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น243.72 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น403.11 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น187.19-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น40.77-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น125.10-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น467.06 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA